Oxford & AstraZeneca pause COVID-19 trial as participant falls ill
Phase 3 clinical trials for the COVID-19 vaccine named AZD1222, developed by AstraZeneca and Oxford University, have been paused after
Read more
COVID-19
Coronavirus (COVID-19) pharmaceutical industry updates
Read the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
Lilly starts Phase 3 Trial of monoclonal antibody for COVID-19 prevention
Eli Lilly and Company announced the start of BLAZE-2, a Phase 3 study of the monoclonal antibody LY-CoV555 vaccine candidate
Read more
Sanofi and GSK progress talks with EU for 300 million COVID-19 vaccines
Sanofi and GSK are in preliminary talks with the European Commission (EC) on the supply of up to 300 million
Read more
Oxford & AstraZeneca COVID-19 vaccine triggers immune response
Results from the ongoing Phase I/II COVID-19 vaccine trial, led by the University of Oxford, showed the AZD1222 vaccine developed
Read more
U.K. buys 90 Million Pfizer, BioNTech and Valneva COVID-19 Vaccines
The United Kingdom has signed and finalised the negotiations for the procurement of 90 million doses of vaccines in development
Read more
Moderna’s mRNA COVID-19 vaccine generates antibodies in Phase I trial
Moderna’s COVID-19 vaccine candidate generated antibodies in all 45 patients studied in its early stage human trial, the U.S biotech
Read more
Russia’s Sechenov University claims world’s first COVID-19 vaccine
At a time when pharma and biotech companies worldwide are racing to develop a vaccine, researchers at the University of
Read more
Sanofi and GSK close to reaching $624 Million U.K. Vaccine Deal
Sanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read more
Tesla to help COVID-19 vaccine developer CureVac with molecule printers
Tesla Inc is engineering mobile molecule printers to help produce the future COVID-19 vaccine developed by CureVac in Germany, the
Read more
Clover begins trials of COVID-19 vaccine with Dynavax and GSK adjuvants
The Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read more